Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleThe development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play.AuthorsAzeggagh, Sonia; Berwick, Daniel C.PublicationBritish Journal of Pharmacology, 2022, Vol 179, Issue 8, p1478ISSN0007-1188Publication typeArticleDOI10.1111/bph.15575